News
Glaucoma is one of the world’s leading causes of irreversible blindness, and currently, no therapies exist to directly protect retinal ganglion cells (RGC) from degradation and loss. NIH inventors have developed a method to treat glaucoma using exosomes derived from bone marrow-derived mesenchymal
Job Postings Opening October 11 ! Remote Positions Available! Are you interested in making an impact to the improvement of global health? Are you interested in working in a dynamic organization that values its employees and offers work-life flexibilities? The National Institute of Allergy and
The AUTM Oncology Partnering Forum on October 20 th is a unique opportunity to network with industry partners and take an in-depth look at the oncology technology sectors. Among the highlights will be a panel presentation from industry partners on trends in this focused area, how industry wants to
The Maryland Life Sciences Bio Innovation Conference is a great opportunity for global brands, venture capitalists, and promising startups to connect with top life sciences professionals in Maryland and the surrounding area. This year’s conference covers a variety of topics including